Codexis, Inc. CDXS
1.08 USD +0.04 (+3.35%)
At closeNov 3, 2026, 4:20 PM EST
1.08 0.00 0.00%
After hours · Nov 3, 4:20 PM ET
1.04 Day range 1.08
0.96 52-week range 2.98
- YTD
- -33.74%
- 1 year
- -52.21%
Analyst view
Price target (mean) 7.17 +563.6% upside
Now 1.08
- Target (low)
- 3.00
- Target (mean)
- 7.17
- Target (high)
- 11.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy1
- Buy4
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.02167 | -0.06 – 0.05 | -0.1035 | +79.1% | 27.41M | +3.2% | 6 |
| Next quarter | -0.165 | -0.19 – -0.14 | -0.16 | -3.1% | 13.98M | -18.1% | 2 |
| Current year | -0.69 | -0.79 – -0.57 | -0.9243 | +25.4% | 65.29M | -6.9% | 6 |
| Next year | -0.64 | -0.76 – -0.51 | -0.69 | +7.2% | 66.61M | +2.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 15, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 4, 2024 | Benchmark | Reiterated | — | Hold |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 29, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 19, 2024 | Benchmark | Downgrade | Buy | Hold |
| Aug 9, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 30, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 3, 2024 | Benchmark | Reiterated | Buy | Buy |
| Feb 29, 2024 | Benchmark | Upgrade | Hold | Buy |
| Nov 7, 2023 | Benchmark | Downgrade | Buy | Hold |
| Nov 6, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 1, 2023 | Benchmark | Reiterated | Buy | Buy |
| Aug 14, 2023 | Stifel | Maintained | Buy | Buy |
| Jul 21, 2023 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 9, 2023 | Benchmark | Maintained | — | Buy |
| May 9, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 17, 2023 | Piper Sandler | Maintained | — | Overweight |
| Feb 27, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 19, 2023 | Piper Sandler | Maintained | — | Overweight |
| Nov 7, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 8, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 15, 2022 | Cowen & Co. | Maintained | — | Outperform |
| Jul 15, 2022 | Piper Sandler | Maintained | — | Overweight |
| May 11, 2022 | Stephens & Co. | Maintained | — | Overweight |
| Nov 5, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 15, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 6, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 18, 2021 | HC Wainwright & Co. | Maintained | — | Buy |